☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2017

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Desmopressin (Noqdirna®) has been accepted for restricted in the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults. The restriction limits use to adults aged 65 years and over.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2017' by emailShare 'SMC Update - August 2017' on FacebookShare 'SMC Update - August 2017' on TwitterShare 'SMC Update - August 2017' on LinkedInShare 'SMC Update - August 2017' on reddit


No Comments to “SMC Update - August 2017”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.